Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,536 studies match

clinicaltrialsPublishedShowing 1,251–1,300 of 1,536 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00777101	Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer	completed	Phase 2	233	Puma Biotechnology, Inc.INDUSTRY	31	Aug 9, 2018	clinicaltrials
NCT00494442	Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer(ICEBERG 2)	completed	Phase 2	58	AstraZenecaINDUSTRY	5	Aug 1, 2018